Glutathione transferases are a multigene family of proteins that catalyze the conjugation of toxic electrophiles and carcinogens to glutathione. Glutathione transferase Pi (GSTP) is commonly overexpressed in human tumors and there is emerging evidence that the enzyme has additional cellular functions in addition to its role in drug and carcinogen detoxification. To investigate the unique functions of this enzyme, we have crossed Gstp null mice with an initiated model of colon cancer, the Apc Min mouse. In contrast to the Apc Min/؉ Gstp1/p2 ؉/؉ (Gstp-wt Apc Min ) mice, which rarely develop colonic tumours, Apc Min/؉ Gstp1/p2 ؊/؊ (Gstp-null Apc Min ) mice had a 6-fold increase in colon adenoma incidence, and a 50-fold increase in colorectal adenoma multiplicity, relative to Gstp-wt Apc Min . This increase was associated with early tumor onset and decreased survival. Analysis of the biochemical changes in the colon tissue of Gstp-null Apc Min mice demonstrated a marked induction of many inflammatory genes, including IL-6, IL-4, IFN-␥, and inducible nitric oxide synthase. In support of the induction of inducible nitric oxide synthase, a profound induction of nitrotyrosine adducts was observed. Gstp therefore appears to play a role in controlling inflammatory responses in the colon, which would explain the change in tumor incidence observed. These data also suggest that individual variation in GSTP levels may be a factor in colon cancer susceptibility.
G
lutathione S-transferases play a key role in chemical detoxification by catalyzing the conjugation of reduced glutathione to reactive electrophiles (1) . In a genetic approach to study GST functions, we have generated mice nulled at the glutathione transferase Pi (GSTP) Gstp gene locus (2) . These mice develop normally, are fertile, and show no obvious abnormalities. Topical application of the tumor initiator 7,12-dimethylbenz[a]anthracene, followed by the promoting agent 12-0-tetradecanoylphorbol-13-acetate, resulted in a significant increase in the number of papillomas in null animals (2) . Similarly, increased adenoma formation in the lungs of Gstp-null mice relative to wild-type mice was also observed following dosing with benzo[a]pyrene, 3-methylcholanthene and urethane (3) . In recent studies we have obtained evidence that this protein can also modulate toxicological or carcinogenic response in a manner distinct from its role in chemical detoxification (4) . Further evidence of unique GSTP function is demonstrated by its ability to form protein-protein interactions and regulate the activities of several cellular proteins (JNK and TRAF2) independently of its catalytic function (5, 6) . GSTP has also been shown to potentiate S-glutathionylation reactions following oxidative and nitrosative stress in vitro and in vivo (7) .
To further evaluate the role of GSTP in disease processes, we have investigated whether GSTP can alter colon cancer susceptibility in the Apc Min mouse. Mutations in the Apc gene is a major initiating factor in the aetiology of colorectal cancer in humans (8, 9) . The Apc Min/ϩ mouse model of gastrointestinal tumorigenesis carries an ethylnitrosourea-induced mis-sense mutation of the adenomatous polyposis coli (Apc) gene at codon 850, which results in truncation of the APC protein (10) . As a consequence, mutant APC is no longer able to bind ␤-catenin and induce its proteosomal degradation (11) . ␤-Catenin is consequently transported into the nucleus and drives the Wnt signaling cascade, resulting in adenoma development predominantly in the small intestine of mice (10) . Here, we report a profoundly increased adenoma incidence and multiplicity in the distal colon of Apc Min mice on a Gstp-null background. Furthermore, we also report that the absence of GSTP in the murine colon results in an inflammatory tissue environment consistent with some of the risk factors associated with colon cancer in humans. (Gstp-null Apc Min ) mice had an altered phenotype was seen in the greatly increased frequency of rectal prolapse and bleeding (63% vs. 17%). Gstp-null Apc Min mice also had significantly decreased survival, based on morbidity relative to Gstp-wt Apc Min (median 21.5 weeks vs. Ͼ30 weeks) (Fig. 1) . The colons of Gstp-null Apc Min mice, killed as a result of ill-health, had a 3.5-fold increase in colorectal adenoma incidence (i.e., mice displaying at least a single adenoma; 71% vs. 20%, n ϭ 30), and a 23-fold increase in colorectal adenoma multiplicity (average number of adenomas per mouse; 4.5 vs. 0.2, n ϭ 30), relative to Gstp-wt Apc Min colons ( Fig. 2A) .
Results

Gstp-null Apc
Min mice that survived to 30 weeks had a sixfold increase in adenoma incidence in the distal colon and a 17% increase in the mid-section of the small intestine (Fig. 2B ). In contrast, in distal portions of the small intestine, a slight decrease (19%) in adenoma incidence was measured (Fig. 2B ). Accompanying the increase in adenoma incidence, a 50-fold increase in adenoma multiplicity (average number of adenomas per mouse) occurred in the distal colon (Fig. 2C ). Adenoma multiplicity did not differ significantly between genotypes for any segment of the small intestine investigated. The colonic adenomas in Gstp-null Apc Min and Gstp-wt Apc Min groups could not be distinguished on gross morphology (see Fig. 2 A and D) . The loss of Gstp therefore profoundly increased the incidence and multiplicity of colonic adenomas in Gstp-null Apc Min mice.
Adenoma Pathology. The histopathology of the tumors from each genotype was very similar. Tumors were predominantly tubular adenomas with a pedunculated morphology protruding into the colonic lumen ( Fig. 3 A and B) . There was no evidence of invasion of the underlying submucosa by neoplastic epithelial cells, and therefore none of the adenomas examined were classified as being carcinomas. Adenomas of both genotypes had high-grade dysplasia Studies into the Mechanism of the GSTP Effects. GSTP could influence colon carcinogenesis by a number of different mechanisms. We therefore carried out a series of experiments to gain further insights into the pathways involved.
It has been reported that deletion of GSTP results in the increased proliferation of both bone marrow-derived mast cells and embryonic fibroblasts (14, 15) . To investigate if there was increased proliferation in the colons of Gstp-null Apc Min mice, migration of enterocytes along the crypt-villus axis was scored after exposure to BrdU for either 2 h or 48 h. No difference between Gstp-wt Apc Min and Gstp-null Apc Min mice was noted in the migration rates of cells along the crypt-villus axis (Fig. 4) , as noted by an equivalent shift to the right for both genotypes, indicating similar cellular proliferation rates.
Increased Inflammation in the Distal Colon of Gstp-Null Apc Min Mice.
mRNA expression profiles within the distal colon were determined by microarray analyses on both Gstp1/p2 ϩ/ϩ and Gstp1/p2 Ϫ/Ϫ animals. In Gstp1/p2 Ϫ/Ϫ colons, the expression of 308 genes was significantly increased and the expression of 202 genes significantly decreased by a factor of twofold or greater. Gstp1 mRNA was found to be absent from Gstp1/p2 Ϫ/Ϫ colon tissue, consistent with deletion Min (n ϭ 30, 21 males and 9 females) and Gstp-null Apc Min mice (n ϭ 32, 22 males and 10 females). These data are based on observed morbidity: that is, repeated rectal prolapse, rectal bleeding, blood in feces, within the terms of the Animal (Scientific Procedures) Act (1986). of the gene (Table S1 ). Interestingly, of the overexpressed genes, a significant number were associated with an inflammatory response, including Saa2, Saa1, STAT1, and IL-4, as well as genes involved in immune response, mast-cell proteases Mcpt1, 2, 4, and 9 (see Table  S1 ). Unbiased pathway enrichment profiling of the up-regulated genes confirmed the induction of inflammation-related changes (Table S2) . Genes whose expression was reduced in the distal colon of Gstp1/p2 Ϫ/Ϫ mice included genes involved in development, cell adhesion, and the cytoskeleton.
The majority of the inflammation-related changes were also found in the colons of Gstp-null mice carrying the Apc Min mutation (Table S3 and S4) . Particular to Gstp-null Apc Min mice, however, were increases in IL-6 (3.2-fold induction) and a 2.8-fold induction in inducible nitric oxide synthase (iNOS, NOS2), both proteins being implicated in inf lammationmediated carcinogenesis. Repression of the cryptdin relatedsequences 2 and 10 (18-and 8-fold, respectively), key molecules in the prevention of bacterial damage to the epithelial cells of the intestine, was also noted. The differences in the profiles between the Gstp-null and Gstp-null Apc Min suggests that there is some crosstalk between the GSTP effects and the Apc Min phenotypes. To investigate the inflammatory changes further, we analyzed colon tissue for the presence of mast cells, neutrophils, and macrophages by immunohistochemistry. Substantial numbers of both macrophages (Fig. 5 A and B) and neutrophils ( Table S3 ), substantially increased levels of mast cells were found in the distal colon of Gstp-null Apc Min mice relative to Gstp-wt Apc Min colons ( Fig. 5 E and F) . In addition to analysis in normal tissue, mRNA profiles were also determined in the colonic adenomas from both Gstp-wt Apc Min and Gstp-null Apc Min mice (Table S5) . Although genes were expressed at higher levels in Gstp-null Apc Min vs.
Gstp-wt Apc
Min adenomas, the differences were relatively small and no differences in activated pathways were clearly identifiable. Interestingly, the differences in cytokines and inflammatorymediated expression observed in the Gstp-null colon were not found between the adenoma samples, suggesting that the changes arose from the infiltration of inflammatory cells rather than from the epithelial cells themselves. A striking difference between the adenoma samples was the reduction in expression of cryptdin related-sequences. Defcr-rs 2, 10, 7, and 12 were particularly prominent, and all repressed by more than a 100-fold in adenomas from Gtsp-null Apc Min mice. We have previously described the altered expression of genes involved in mucin production (Gob-5 and Gob-4) in the lungs of Gstp1/p2 Ϫ/Ϫ mice (3). Reduced mucin production in the intestine accompanies both inflammatory bowel disease and colon cancer and has been postulated as allowing irritation of the underlying epithelial cells by the intestinal microbiota (16). To investigate the possibility that altered mucin production, as a consequence of Gstp deletion, was a possible mechanism for the observed increase in inflammation noted in the distal colons of Gstp-null Apc Min mice, we stained colon tissue with alcian blue to detect mucous-producing goblet cells. No difference in goblet cell numbers was noted between Gstp-wt Apc Min and Gstp-null Apc Min distal colon ( Fig. 6 A and B) . Given the increased expression of iNOS in the colon of Gstp-null Apc Min mice (see Table S3 ), and because changes in nitric oxide production could account for the some of the inflammatory changes observed and the alteration in colon carcinogenesis, we investigated nitrotyrosine levels in the colons of Gstp-wt Apc Min and Gstp-null Apc Min mice. In the absence of Gstp, a profound increase in nitrotyrosine levels was observed ( Fig. 6 C and D) . The increased production of nitric oxide could also be a consequence of an increased level of oxidative stress; however, no changes in the expression of proteins commonly induced by oxidative stress, including heme oxygenase 1, and NQO1, were found (Fig. S2) . We also measured 8-oxo-7,8-dihydro-20-deoxyguanosine (8-oxodG) and 8-oxo-7,8-dihydro-20-deoxyadenosine (8-oxodA), two of the most common DNA adduct biomarkers for oxidative stress. No difference in either of these DNA adducts was noted between Gstp-wt Apc
Min and Gstp-null Apc Min mice (Fig. S3) . 
Discussion
We have investigated whether GSTP modulates pathways of colon tumorigenesis in a manner which is distinct from its role in the detoxification of carcinogenic electrophiles. The Gstp-null phenotype profoundly increased the incidence, and particularly the multiplicity, of colorectal adenomas in the Apc Min mouse, providing strong evidence that this gene can alter cancer susceptibility by previously unrecorded mechanisms. This in vivo evidence is unique in showing that Gstp can alter tumorigenicity in a model that does not involve carcinogens, and suggests that variation in GSTP expression could influence colon cancer susceptibility. Human GSTP can be regulated by a number of pathways including AP1, retinoic acid, and p53 signaling (17-19). Using a mouse humanized for the Gstp gene, we are currently investigating whether GSTP can be regulated in the colon by chemopreventative agents such as ethoxyquin, butylated hydroxyanisole, and sulforaphane. On this basis, it would be very interesting to evaluate any changes in the incidence of colon cancer in populations receiving chemopreventative agents; for example, there is the trial in Qidong city, China, investigating the potential of Oltipraz to prevent liver cancer (20) .
A number of studies have reported an increase in colon adenomas on an Apc Min genetic background;
and Er␤ Ϫ/ϪMin/ϩ (2.5-fold) (21-23). As reported in the present study, the effects of the absence of Gstp on the Apc Min background appear to be particularly profound with regards to tumor multiplicity (50-fold increase). We have carried out a number of experiments to establish the basis of the increased tumor incidence in Gstp-null Apc Min mice. The absence of Gstp does not appear to alter the level of DNA adducts, or other markers such as heme oxygenase 1 or quinone reductase, resulting from oxidative stress, nor does it increase cell proliferation rates or mucin production in the colonic epithelium. Indeed, the most striking change in the normal colon of Gstp-null Apc Min mice was in pathways linked with inflammatory response, appearing, at least in part, to be related to a significant increase in mast cell infiltration. Mast cells have also been reported as being an essential hematopoietic component of the development of adenomatous polyps (24), and microarray data from this study provided further support for their involvement with significantly increased expression of mast cellrelated genes. Increased mast cell numbers have also been observed in patients with ulcerative colitis and Crohn disease, both of which are risk factors in colon cancer susceptibility (25, 26) .
Unbiased pathway enrichment analysis of the mRNA profiles suggested significant changes in pathways associated with inflammation. Related to this, normal colonic tissue from Gstp-null Apc Min mice had significantly increased expression of several interleukins (IL-4 and IL-6) and interleukin receptors. Of particular note was the expression of IL-6 (3.2-fold induction), a major proinflammatory cytokine that participates in inflammationassociated carcinogenesis and which has been found to positively correlate with tumor load in colon cancer patients, and promote anchorage-independent growth of human colon carcinoma cells (27, 28) . Indicative that this increase in IL-6 gene expression is of biological significance, several pathways known to be modulated by IL-6 signaling, including major inflammatory pathways such as STAT1, IFN-␥, and TGF-␤ (29-31), were also found to be modulated in the colon of Gstp-null Apc Min mice. Interestingly, such changes in cytokine expression were not observed in the adenomas, suggesting that the changes observed arise-directly or indirectlyfrom the presence of infiltrating immune cells. There is increasing evidence that GSTP is involved in the regulation of inflammation (32, 33), and recent reports suggest that the Phase-2 family of drug metabolizing enzymes as a whole have a significant role to play in the suppression of inflammation (34).
Inducible nitric oxide synthase (iNOS, NOS2), was increased in the colon of Gstp-null Apc Min mice, and this was reflected in a marked increase in nitrotyrosine protein adducts. There is now strong evidence that NO itself, through its proinflammatory effects, may play an important role in carcinogenesis (35). The increase in iNOS activity may well be a consequence of the proinflammatory environment in the colon of Gstp-null Apc Min mice.
A further potential mechanism for the source of the increased inflammation observed in colonic tissue lacking GSTP is seen in the microarray data, which shows a striking reduction in the expression of cryptdin-related genes, both in normal tissue and in adenomas derived from Gstp-null mice. Cryptdins, known also as ␣-defensins in humans, are important antibacterial peptides secreted from the Paneth cells in the intestinal crypts, which selectively insert into the membranes of bacteria to create pores and instigate lysis (36). Significantly, a reduction in cryptdin expression is consistently seen in sufferers of inflammatory bowel disease and is thought to result in an imbalance in the amount of virulent bacteria present in the gut, leaving the area prone to immune-mediated intestinal injury (37).
GSTP therefore appears to protect the colon against the development of a pro-inflammatory environment, although the mechanisms by which GSTP may influence such pathways or the inflammatory response remains unclear. However, GSTP can modulate down-stream effector pathways of reactive nitrogen species, including the MAPK signaling cascade, in which JNK, a protein inhibited by GSTP, is an important mediator (5, 38, 39). Another intriguing possibility is the emerging role for GSTP in controlling protein glutathionylation (7).
In conclusion, the Gstp-null Apc Min mouse provides an excellent model for understanding environmental influences on the aetiology of colorectal cancer and could also offer a useful system for investigating the efficacy of novel therapies for the prevention and treatment of this disease.
Methods
Reagents. All chemicals were purchased from Sigma or Fisher Scientific Ltd..
Animals.
Experiments were undertaken in accordance with the Animals (Scientific Procedures) Act of 1986 and approved by the Animal Ethics Committees of the University of Dundee and Cancer Research U.K. Gstp1/p2 null and wild-type mouse lines, on a 129 ϫ MF1 background, were generated and maintained by random inter-crossing to sustain a heterogeneous mixed genetic background as To produce Apc Min/ϩ Gstp1/p2 Ϫ/Ϫ mice (referred to as Gstp-null Apc Min ), Gstp1/p2 Ϫ/Ϫ mice were bred with Apc Min mice on a C57BL/6 background to produce Apc Min/ϩ Gstp1/p ϩ/Ϫ mice. These mice were then crossed onto either Gstp1/p2 Ϫ/Ϫ or Gstp1/p2 ϩ/ϩ mice to produce Apc Min/ϩ Gstp1/p2 Ϫ/Ϫ , Apc ϩ/ϩ Gstp1/ p2 Ϫ/Ϫ , and Apc ϩ/ϩ Gstp1/p2 ϩ/ϩ , Apc Min/ϩ Gstp1/p2 ϩ/ϩ (referred to as Gstp-wt Apc Min ) respectively. Animals were then either used for experiments or crossed again into Gstp1/p2 Ϫ/Ϫ or Gstp1/p2 ϩ/ϩ mouse genotypes to generate further Gstp-null Apc Min and Gstp-wt Apc Min mice.
Genotyping. For determination of Gstp genotype PCR was carried-out using tail DNA using the following primers:
For Gstp1, 5Ј-GGC CAC CCA ACT ACT GTG AT-3Ј and 5Ј-AGA AGG CCA GGT CCT AAA GC-3Ј, giving a 200-bp band.
For Lac-Z insert, 5Ј-CTG TAG CGG CTG ATG TTG AA-3Ј and 5Ј-ATG GCG ATT ACC GTT GAT GT-3Ј, giving a 309-bp band.
For detection of the Apc Min mutation, tail DNA was genotyped using published conditions in ref. 40.
Intestinal Histopathology. Mice were killed at defined time-points or when showing signs of intestinal neoplasia, such as hunching, pale feet, swollen abdomen, and prolapse. The entire intestine was removed and the small intestine divided into three equal sections, with a fourth section comprising the entire large intestine. Intestine segments were flushed with PBS and opened longitudinally onto Whatmann 3MM paper or made into ''Swiss-roll'' preparations for detailed histological analyses. Both preparations were fixed overnight at 4°C in 10% neutral buffered formalin. Adenomas were visualized by staining with 0.2% methylene blue, and identified, counted, and measured with the aid of a Zeiss dissecting microscope with Axiovision imaging software. For detailed histological analysis, H&E sections were prepared from Swiss-roll specimens by standard techniques. To assess mucin production, slides were treated with Alcian Blue (pH 2.5) for 5 min, then mounted using standard techniques.
In Vivo Migration Assays. In vivo migration was scored as described in ref. 41 . To assess rates of in vivo proliferation, cellular proliferation labeling agent (Amersham) containing BrdU was given i.p at 10 l per gram body weight. Mice were then killed at 2 h and 48 h and Swiss-roll gut preparations produced and fixed as previously described. For each analysis, 25 full crypts were scored from at least three mice of each genotype.
Immunohistochemistry. To detect BrdU incorporation and nitrotyrosine levels, sections were dewaxed and rehydrated using standard techniques and then underwent microwave antigen retrieval using 10-mM citrate buffer for 10 min. Immunohistochemistry was then carried-out using the Dako Envision staining system with a 1:50 dilution of anti-BrdU antibody (Becton Dickinson) or anti-nitrotyrosine antibody (Millipore). For detection of mast cells, neutrophils and macrophage gut tissue was fixed in methacarn (4:2:1 methanol, chloroform and glacial acetic acid) overnight at 4°C and in 4% formalin for an additional 24 h. For the detection of mast cells, slides were stained with toluidine blue (pH 2.3) for 5 min. Macrophages were detected by probing appropriately prepared sections with a 1:100 dilution of anti-F4/80 antibody (Abcam) and, similarly, neutrophils detected by probing sections with a 1:1,000 dilution of anti-myeloperoxidase antibody (Dako). Signals were developed by standard techniques.
Isolation of RNA.
To isolate RNA from colon tissue, week-10 mice were killed by cervical dislocation and the last 5 cm of the colon flushed with PBS and immediately snap-frozen. RNA was then isolated using TRIzol (Invitrogen) and further purified with an RNeasy Mini Kit (Qiagen). The A260/280 ratio of total RNA used was typically Ն1.9. The quality of RNA was assessed by using an Agilent 2100 Bioanalyzer (Agilent Technologies).
Microarray Analysis. Total RNA (1 g) was labeled with Cyanine 3 (Cy3)-CTP according to the Agilent One-Color Microarray-Based Gene Expression Analysis protocol version 5.0.1 using the Low Input RNA Fluorescent Linear Amplification Kit (Agilent). Agilent 4 ϫ 44K Whole Mouse Genome Oligo Microarray slides were hybridized and washed using Agilent hybridization and wash buffers, and scanned at 5 M resolution on an Agilent Microarray Scanner. Images from the scanner were processed using Agilent Feature Extraction Software v9.1. The microarray scanned image and intensity files were imported into Rosetta Resolver gene-expression analysis software version 6.0.0.0.1. Individual expression profiles from the various genotypes (Apc Min/ϩ Gstp1/p2 Ϫ/Ϫ , Apc ϩ/ϩ Gstp1/p2 Ϫ/Ϫ , and Apc ϩ/ϩ Gstp1/p2 ϩ/ϩ , Apc Min/ϩ Gstp1/p2 ϩ/ϩ ) were pooled in silico by calculating an error-weighted mean and compared to build ratios. Data were then analyzed using Bioconductor 2.2 and normalized using quantile normalization. Differential gene expression was assessed between comparison groups using an empirical Bayes t test. Probes that exhibited an adjusted P value of Ͻ0.05 and an absolute fold-change of Ͼ2 were called differentially expressed. Probes that exhibited an adjusted P value of Ͻ0.05 were also used for enrichment analysis using Genego's Metcore pathway tool to identify enriched pathways and biological processes.
Molecular Analysis of Adenomas.
To enable molecular analysis of adenomas, small portions of colorectal adenomas were carefully harvested with the aid of a dissecting microscope to minimize stromal contamination. DNA was then isolated from each adenoma sample using the Wizard SV Genomic Purification System (Promega) according to the manufacturer's instructions. For the mutation analysis, selected regions in KRAS and p53 were amplified using the following specific oligonucleotide primers. For p53 mutational analysis, exons 5, 6, and 8 were probed for mutations using the following primers:
For mutational analysis of KRAS codons 12 or 13, the following primers were used: KRAS 1S (5-TTATTGTAAGGCCTGCTGAA-3), KRAS 1AS (5-GCAGCGTTACCTCTATCGTA-3). PCR products for KRAS and p53 were purified using the QIAGEN PCR purification kit before sequencing. Mutations in codons were detected by direct sequencing using the previously described amplification primers. The sequencing was performed by the DNA Analysis Facility at Ninewells Hospital, Dundee, United Kingdom.
Statistical Analysis. We performed statistical analyses using GraphPad Quickcalcs Online statistical calculator or SPSS. Significant differences when comparing two groups were determined by unpaired t test. P values were considered significant if they were Ͻ0.05. Tissue Harvest. The last 5 cm of the distal colon was harvested from 10-week-old mice and immediately frozen. The frozen tissue was then ground into a fine powder using a pestle and mortar containing liquid nitrogen. The ground tissue was then weighed and three times weight-to-volume added of tissue lysis buffer (50 mM Tris⅐HCl pH 7.5, 1 mM EDTA, 1 mM EGTA, 1 mM sodium orthovanadate, 10 mM sodium ␤-glycerophosphate, 50 mM sodium fluoride, 5 mM sodium pyrophosphate, 0.27 M sucrose, 1% (vol/vol) Triton x-100, 0.1% (vol/vol) 2-mercaptoethanol, and protease inhibitor mixture (one tablet/50 ml). The lysates were then centrifuged at 16,000 ϫ g for 10 min at 4°C and the supernatants stored at Ϫ20°C.
Immunoblotting. Samples were denatured in SDS before being run on polyacrylamide gels, after which they were transferred to nitrocellulose membranes. The membranes were then blocked for 1 h at room temperature in 50 mM Tris⅐HCl pH 7.5, 150 mM NaCl, 0.2% Tween (TBST), and 5% skimmed milk powder. Membranes were then incubated overnight at 4°C with gentle rocking with antisera to Gstp1, Gstm1, Gsta1 NQ01, HO-1 (Abcam) or actin (Sigma) in TBST 5% BSA. The following day, membranes were washed three times with TBST (5 min per wash) and then exposed to secondary antibody in TBST containing 5% (wt/vol) skimmed milk powder. Membranes were then washed four times with TBST (5 min per wash) and immunoreactive proteins visualised with ECL plus (Amersham) reagent according to the manufacturer's instructions. Stripping of membranes, if required, was accomplished using Re-Blot Plus mild antibody stripping solution (Chemicon International).
DNA Adduct Determination.
Oxidative DNA adducts were determined as described in ref. 2. 
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